April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
April 8, 2024 Robotaxi Revolution: Hype or Reality?
Apple’s Technical Climb To $240 By Year-End
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Medicenna Therapeutics (MDNA) Stock Forecast for 2024–2028. Sell or Buy?
Updated: March 18, 2024 (11:00)
Sector: HealthcareThe share price of Medicenna Therapeutics Corp. (MDNA) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Medicenna Therapeutics stocks, the 50-day moving average is the support level today.
For Medicenna Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Medicenna Therapeutics share be worth in 2024 - 2028?
When should I take profit in Medicenna Therapeutics stock? When should I record a loss on Medicenna Therapeutics stock? What are analysts' forecasts for Medicenna Therapeutics stock? What is the future of Medicenna Therapeutics stock? We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on Medicenna Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Medicenna Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medicenna Therapeutics shares. This happens once a day.
Historical and forecast chart of Medicenna Therapeutics stock
The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Medicenna Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
Medicenna Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 14 | 0.32 | 0.31 | 0.32 | 3.45 |
| Sep 15 | 0.32 | 0.31 | 0.33 | 4.44 |
| Sep 16 | 0.33 | 0.32 | 0.33 | 3.94 |
| Sep 17 | 0.33 | 0.32 | 0.34 | 4.61 |
| Sep 18 | 0.33 | 0.32 | 0.33 | 4.16 |
| Sep 19 | 0.33 | 0.33 | 0.34 | 5.53 |
| Sep 20 | 0.33 | 0.32 | 0.34 | 4.86 |
| Sep 21 | 0.32 | 0.31 | 0.33 | 5.44 |
| Sep 22 | 0.33 | 0.32 | 0.33 | 5.17 |
| Sep 23 | 0.32 | 0.31 | 0.32 | 4.09 |
| Sep 24 | 0.33 | 0.32 | 0.33 | 4.62 |
| Sep 25 | 0.32 | 0.32 | 0.33 | 2.44 |
| Sep 26 | 0.33 | 0.33 | 0.34 | 4.55 |
| Sep 27 | 0.35 | 0.34 | 0.35 | 4.14 |
| Sep 28 | 0.35 | 0.35 | 0.35 | 2.40 |
| Sep 29 | 0.35 | 0.34 | 0.36 | 2.97 |
| Sep 30 | 0.34 | 0.34 | 0.35 | 3.43 |
| Oct 01 | 0.35 | 0.34 | 0.35 | 3.93 |
| Oct 02 | 0.33 | 0.33 | 0.34 | 2.39 |
| Oct 03 | 0.33 | 0.33 | 0.34 | 4.10 |
| Oct 04 | 0.33 | 0.32 | 0.33 | 5.36 |
| Oct 05 | 0.32 | 0.31 | 0.32 | 3.59 |
| Oct 06 | 0.33 | 0.32 | 0.33 | 3.96 |
| Oct 07 | 0.33 | 0.32 | 0.33 | 3.18 |
| Oct 08 | 0.34 | 0.33 | 0.35 | 4.13 |
| Oct 09 | 0.35 | 0.35 | 0.36 | 3.56 |
| Oct 10 | 0.36 | 0.35 | 0.36 | 3.33 |
| Oct 11 | 0.34 | 0.34 | 0.35 | 5.19 |
| Oct 12 | 0.34 | 0.33 | 0.34 | 4.35 |
| Oct 13 | 0.34 | 0.33 | 0.34 | 3.69 |
Medicenna Therapeutics Daily Price Targets
Medicenna Therapeutics Stock Forecast 09-14-2023.
Forecast target price for 09-14-2023: $0.32.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.332%.
Pessimistic target level: 0.31
Optimistic target level: 0.32
Medicenna Therapeutics Stock Forecast 09-15-2023.
Forecast target price for 09-15-2023: $0.32.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 4.247%.
Pessimistic target level: 0.31
Optimistic target level: 0.33
Medicenna Therapeutics Stock Forecast 09-16-2023.
Forecast target price for 09-16-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.795%.
Pessimistic target level: 0.32
Optimistic target level: 0.33
Medicenna Therapeutics Stock Forecast 09-17-2023.
Forecast target price for 09-17-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 4.410%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
Medicenna Therapeutics Stock Forecast 09-18-2023.
Forecast target price for 09-18-2023: $0.33.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.996%.
Pessimistic target level: 0.32
Optimistic target level: 0.33
Medicenna Therapeutics Stock Forecast 09-19-2023.
Forecast target price for 09-19-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.243%.
Pessimistic target level: 0.33
Optimistic target level: 0.34
MDNA (MDNA) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 0.33 | 0.29 | 0.35 | 16.14 |
| Jun. | 0.35 | 0.30 | 0.37 | 17.91 |
| Jul. | 0.37 | 0.32 | 0.38 | 15.68 |
| Aug. | 0.35 | 0.31 | 0.38 | 17.18 |
| Sep. | 0.32 | 0.29 | 0.37 | 21.71 |
| Oct. | 0.38 | 0.34 | 0.43 | 20.49 |
| Nov. | 0.38 | 0.33 | 0.43 | 23.63 |
| Dec. | 0.35 | 0.32 | 0.40 | 20.06 |
Medicenna Therapeutics forecast for this year
Medicenna Therapeutics Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $0.329449. Pessimistic: $0.29. Optimistic: $0.35
Medicenna Therapeutics Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $0.353235. Pessimistic: $0.30. Optimistic: $0.37
Medicenna Therapeutics Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $0.367329. Pessimistic: $0.32. Optimistic: $0.38
Medicenna Therapeutics Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $0.345693. Pessimistic: $0.31. Optimistic: $0.38
Medicenna Therapeutics Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $0.322048. Pessimistic: $0.29. Optimistic: $0.37
Medicenna Therapeutics Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $0.378342. Pessimistic: $0.34. Optimistic: $0.43
Medicenna Therapeutics Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.382655. Pessimistic: $0.33. Optimistic: $0.43
Medicenna Therapeutics Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $0.352846. Pessimistic: $0.32. Optimistic: $0.40
Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.33 | 0.30 | 0.37 | 18.06 |
| Feb | 0.33 | 0.31 | 0.37 | 16.85 |
| Mar | 0.31 | 0.27 | 0.34 | 20.48 |
| Apr | 0.32 | 0.27 | 0.34 | 21.49 |
| May | 0.37 | 0.31 | 0.41 | 23.58 |
| Jun | 0.35 | 0.32 | 0.39 | 16.88 |
| Jul | 0.33 | 0.29 | 0.34 | 16.26 |
| Aug | 0.38 | 0.34 | 0.40 | 16.20 |
| Sep | 0.39 | 0.34 | 0.44 | 24.32 |
| Oct | 0.40 | 0.39 | 0.42 | 7.66 |
| Nov | 0.37 | 0.33 | 0.39 | 14.23 |
| Dec | 0.32 | 0.27 | 0.36 | 23.22 |
Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.28 | 0.24 | 0.31 | 22.30 |
| Feb | 0.30 | 0.28 | 0.32 | 11.36 |
| Mar | 0.26 | 0.24 | 0.29 | 18.85 |
| Apr | 0.24 | 0.21 | 0.27 | 22.59 |
| May | 0.24 | 0.22 | 0.27 | 18.47 |
| Jun | 0.25 | 0.23 | 0.27 | 16.66 |
| Jul | 0.30 | 0.27 | 0.33 | 17.60 |
| Aug | 0.25 | 0.23 | 0.28 | 19.85 |
| Sep | 0.21 | 0.20 | 0.23 | 11.69 |
| Oct | 0.22 | 0.20 | 0.23 | 12.72 |
| Nov | 0.20 | 0.19 | 0.22 | 13.07 |
| Dec | 0.21 | 0.19 | 0.23 | 17.77 |
Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.20 | 0.18 | 0.22 | 15.18 |
| Feb | 0.21 | 0.19 | 0.23 | 17.75 |
| Mar | 0.24 | 0.21 | 0.27 | 21.03 |
| Apr | 0.27 | 0.26 | 0.29 | 9.02 |
| May | 0.25 | 0.23 | 0.28 | 17.52 |
| Jun | 0.27 | 0.26 | 0.29 | 11.69 |
| Jul | 0.26 | 0.23 | 0.28 | 18.40 |
| Aug | 0.27 | 0.24 | 0.29 | 15.10 |
| Sep | 0.29 | 0.27 | 0.33 | 18.90 |
| Oct | 0.27 | 0.23 | 0.28 | 16.54 |
| Nov | 0.29 | 0.25 | 0.30 | 17.69 |
| Dec | 0.26 | 0.24 | 0.29 | 17.87 |
Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.25 | 0.22 | 0.28 | 20.32 |
| Feb | 0.27 | 0.26 | 0.30 | 12.08 |
| Mar | 0.29 | 0.26 | 0.32 | 19.41 |
| Apr | 0.26 | 0.23 | 0.28 | 19.49 |
| May | 0.26 | 0.22 | 0.30 | 26.10 |
| Jun | 0.29 | 0.27 | 0.33 | 18.96 |
| Jul | 0.30 | 0.28 | 0.31 | 10.03 |
| Aug | 0.33 | 0.29 | 0.34 | 15.99 |
| Sep | 0.35 | 0.33 | 0.38 | 13.04 |
| Oct | 0.36 | 0.34 | 0.39 | 13.35 |
| Nov | 0.34 | 0.31 | 0.37 | 14.38 |
| Dec | 0.35 | 0.32 | 0.40 | 20.79 |
Medicenna Therapeutics information and performance
N/A
Market capitalization of the Medicenna Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDNA shares in the company outstanding by the market price of one share.
EBITDA of Medicenna Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
